...
首页> 外文期刊>Revista Panamericana de Salud Pública >The epidemiology of renal replacement therapy in two different parts of the world: the Latin American Dialysis and Transplant Registry versus the European Renal Association-European Dialysis and Transplant Association Registry
【24h】

The epidemiology of renal replacement therapy in two different parts of the world: the Latin American Dialysis and Transplant Registry versus the European Renal Association-European Dialysis and Transplant Association Registry

机译:肾脏替代疗法在世界上两个不同地区的流行病学:拉丁美洲透析和移植注册中心与欧洲肾脏协会-欧洲透析和移植协会注册中心

获取原文
           

摘要

Objective To compare the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in Latin America and Europe, as well as to study differences in macroeconomic indicators, demographic and clinical patient characteristics, mortality rates, and causes of death between these two populations. Methods We used data from 20 Latin American and 49 European national and subnational renal registries that had provided data to the Latin American Dialysis and Renal Transplant Registry (RLADTR) and the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry, respectively. The incidence and prevalence of RRT in 2013 were calculated per million population (pmp), overall and by subcategories of age, sex, primary renal disease, and treatment modality. The correlation between gross domestic product and the prevalence of RRT was analyzed using linear regression. Trends in the prevalence of RRT between 2004 and 2013 were assessed using Joinpoint regression analysis. Results In 2013, the overall incidence at day 91 after the onset of RRT was 181 pmp for Latin American countries and 130 pmp for European countries. The overall prevalence was 660 pmp for Latin America and 782 pmp for Europe. In the Latin American countries, the annual increase in the prevalence averaged 4.0% (95% confidence interval (CI): 2.5%-5.6%) from 2004 to 2013, while the European countries showed an average annual increase of 2.2% (95% CI: 2.0%-2.4%) for the same time period. The crude mortality rate was higher in Latin America than in Europe (112 versus 100 deaths per 1 000 patient-years), and cardiovascular disease was the main cause of death in both of those regions. Conclusions There are considerable differences between Latin America and Europe in the epidemiology of RRT for ESRD. Further research is needed to explore the reasons for these differences.
机译:目的比较拉丁美洲和欧洲用于终末期肾脏疾病(ESRD)的肾脏替代疗法(RRT)的流行病学,并研究宏观经济指标,人口统计学和临床​​患者特征,死亡率和死亡原因之间的差异在这两个人群之间。方法我们使用了来自20个拉丁美洲和49个欧洲国家和国家以下各级肾脏注册机构的数据,这些数据已为拉丁美洲透析和肾脏移植注册表(RLADTR)和欧洲肾脏协会-欧洲透析和移植协会(ERA-EDTA)注册表提供了数据,分别。 2013年RRT的发生率和患病率按年龄,性别,原发性肾脏疾病和治疗方式的总体和子类别,按百万人口(pmp)计算。使用线性回归分析了国内生产总值和RRT患病率之间的相关性。使用Joinpoint回归分析评估了2004年至2013年间RRT的流行趋势。结果2013年,RRT发生后第91天的总发病率是拉丁美洲国家为181 pmp,欧洲国家为130 pmp。拉丁美洲的总体流行率为660 pmp,欧洲为782 pmp。从2004年到2013年,拉丁美洲国家的患病率平均每年增加4.0%(95%置信区间(CI):2.5%-5.6%),而欧洲国家则平均每年增加2.2%(95%) CI:2.0%-2.4%)。拉丁美洲的粗死亡率高于欧洲(每1000名患者年112例死亡与100例死亡),而心血管疾病是这两个地区的主要死亡原因。结论拉丁美洲和欧洲在ESRD的RRT流行病学方面存在相当大的差异。需要进一步研究以探究这些差异的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号